(Rac) -Eflucimibe
(Rac) -Eflucimibe ((Rac) -F 12511) is an ACAT inhibitor with endogenous hypercholesterolemia modulating activity. (Rac) -Eflucimibe has shown high potency and efficacy as an anti-hypercholesterol compound in different hypercholesterolemia animal models[1].
Product Specifications
CAS Number
191791-65-8
Product Name Alternative
(Rac) -F 12511
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/rac-eflucimibe.html
Smiles
O=C(C(C1=CC=CC=C1)SCCCCCCCCCCCC)NC2=C(C)C(C)=C(O)C(C)=C2
Molecular Formula
C29H43NO2S
Molecular Weight
469.72
References & Citations
[1]Time-dependent evaluation of mechanical properties and in vitro cytocompatibility of experimental composite-based nerve guidance conduits
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TYK2 (Non-receptor Tyrosine-protein Kinase TYK2, JTK1) (PE)
Recombinant Synechococcus sp. Photosystem II reaction center protein H (psbH)
Recombinant Synechococcus sp. Photosystem II reaction center protein H (psbH)
Recombinant Synechococcus sp. Photosystem II reaction center protein H (psbH)
